Tuesday, 21 May 2019

Ceisteanna (454, 457)

John Lahart

Ceist:

454. Deputy John Lahart asked the Minister for Health if he will instruct the HSE to acknowledge that ME can lead to disability from mild to profound; if the HSE will add ME to its list of disabilities (details supplied); his views on whether access to assessment for home support and personal assistance should be through disability services not older person’s services; and if he will make a statement on the matter. [22022/19]

Amharc ar fhreagra

John Lahart

Ceist:

457. Deputy John Lahart asked the Minister for Health if the HSE will implement the international consensus criteria for myalgic encephalomyelitis in order that persons with ME can get a clear diagnosis as soon as possible; and if he will make a statement on the matter. [22025/19]

Amharc ar fhreagra

Freagraí scríofa (Ceist ar Health)

I propose to take Questions Nos. 454 and 457 together.

Chronic fatigue syndrome (CFS) / myalgic encephalomyelitis (or encephalopathy) (ME) is a not uncommon, complex debilitating disorder which is characterised by severe fatigue accompanied by a range of other symptoms.

There is currently no known, specific, medical diagnostic test to determine or confirm a correct diagnosis of ME and no specific treatment which works for all sufferers is currently available. Assessment and interventions need to be tailored to the individual. There are assessments/tests which can be carried out in primary care settings by a General Practitioner. Specialised tests may be required when considering differential diagnoses.

Treatment for ME is tailored to address the varying symptoms presented by those affected by ME. In general, these treatments are delivered within the context of primary care, with referrals into secondary care for specialist interventions in the areas of Neurology, Rheumatology, Pain Specialists, Endocrinology, Immunology, Cardiology, etc. The challenge in relation to ME is that it does not sit within one specialty, but crosses a number of specialties, with patients attending different Consultants for management of symptoms as they arise.

Waiting times for access to these services can be lengthy. However, there is currently work under way as part of the implementation of the Strategy for the Design of Integrated Outpatient Services 2016-2020, specifically as regards addressing how and where the patient is treated and the classification of referrals with corresponding clinically recommended time-frames. Consideration is also being given to condition specific referral forms. This work should see significant improvements with respect to access to appropriate services.

I have asked the Health Service Executive to also respond to you on this matter.